Management of Anticoagulant Therapy Monitored by an Implantable Device With Telecardiology in Patients With Acute Coronary Syndrome Associated With de Novo Atrial Fibrillation Arrhythmia

A phase 4 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 500 participants.

Also called NCT04276155

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 500 participants (planned count) (from the registry)
Sponsor
Centre Hospitalier de PAU (from the registry)
Registry
  • NCT NCT04276155
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
France (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT04276155. Randomized; no masking; primary purpose treatment. Start 2021-08-03 (actual); primary completion 2027-06-22 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Management of Anticoagulant Therapy Monitored by an Implantable Device With Telecardiology in Patients With Acute Coronary Syndrome Associated With de Novo Atrial Fibrillation Arrhythmia
Acronym
SCA FA
Intervention (Drug)
non-systematic prescription of anticoagulant therapy
Lead sponsor
Centre Hospitalier de PAU (class: other)

Record details

Record id
cardio:ct-nct04276155
Content hash
9bf9f12c5011fe5c1f0956f370d0dda80257fc53b79a60aaf0694e58174c1668